World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ChiCTR
Last refreshed on: 18 April 2017
Main ID:  ChiCTR-OOC-15006130
Date of registration: 2014-10-30
Prospective Registration: No
Primary sponsor: The first hospital affiliated of wenzhou medical university
Public title: An observational study:Relaxin levels in patients with atrial fibrillation and its relationship with atrial fibrosis
Scientific title: An observational study:Relaxin levels in patients with atrial fibrillation and its relationship with atrial fibrosis
Date of first enrolment: 2014-04-01
Target sample size: AF Group :200;Control Group:200;
Recruitment status: Completed
URL:  http://www.chictr.org.cn/showproj.aspx?proj=10620
Study type:  Observational study
Study design:  Case-Control study  
Phase:  Other
Countries of recruitment
China
Contacts
Name: Hao Zhou   
Address:  Shangcai South village, Ouhai district, Wenzhou, Zhejiang
Telephone: +86 13968801939
Email: wyzh66@126.com
Affiliation: 
Name: Xiang Qu   
Address:  Shangcai South village, Ouhai district, Wenzhou, Zhejiang
Telephone: +86 13616633181
Email: cookie774@163.com
Affiliation:  The first hospital affiliated of wenzhou medical university
Key inclusion & exclusion criteria
Inclusion criteria: 1.Patients are diagnosed by electrocardiogram as atrial fibrillation;
2.Patients provide voluntarily his/her blood samples and cooperate with treatment and check;
3.Patients are willing to review and follow-up after atrial fibrillation with radiofrequency ablation for 5 to 7 months.

Exclusion criteria: 1.Patients who eventually are diagnosed as other types of arrhythmias;
2.The acute heart failure patients need dialysis or rescue breathing machine;
3.Patients who are hemodynamic instability or myocardial infarction for killip 3-4 level need breathing machine or IABP support;
4.Patients who appear severe complications after ablation, such as injure the his bundle, II or III degree atrioventricular block and cardiac perforation;
5.Any situation that researchers consider the patient's condition will interfere is not be into the group.


Age minimum: 18
Age maximum: 80
Gender: Both
Health Condition(s) or Problem(s) studied
atrial fibrillaiton
Intervention(s)
AF Group :Radiofrequency ablation or conservative treatment ;Control Group:None;
Primary Outcome(s)
Relaxin;Blood;
Secondary Outcome(s)
Secondary ID(s)
Source(s) of Monetary Support
Zhejiang province natural science fund
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history